"GLP-3" is a term often used to describe investigational triple-agonist drugs, most notably retatrutide (LY3437943), which target three receptors (GLP-1, GIP, and glucagon) to manage weight and diabetes. Phase 2/3 trials suggest it can deliver significant weight loss, with some studies showing up to ~24% to 36% reductions in body weight.
Key Information on Retatrutide ("GLP-3")
Every batch is independently third-party tested using HPLC purity analysis and mass spectrometry. We guarantee ≥99% purity on all our research peptides, with a full Certificate of Analysis provided for each lot.
Orders placed before 12PM Pacific Time ship same-day, Monday–Friday. You'll receive a tracking number via email once your order leaves our facility. All orders are shipped with discreet packaging.
